News Releases

June 3, 2019
Urovant Sciences to Present at Annual Roivant Pipeline Day
IRVINE, Calif. & BASEL, Switzerland --(BUSINESS WIRE)--Jun. 3, 2019-- Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical company developing and commercializing innovative therapies for urologic conditions, today announced Chief Executive Officer Keith A.
Additional Formats
March 6, 2019
Urovant Sciences Appoints James Robinson to its Board of Directors
IRVINE, Calif. & BASEL, Switzerland --(BUSINESS WIRE)--Mar. 6, 2019-- Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions, today announced James Robinson , President and Chief Operating
Additional Formats
Displaying 11 - 20 of 25